Most Read Articles
Pearl Toh, 7 days ago
Mepolizumab added on to standard of care for patients with severe eosinophilic asthma better improves health-related quality of life (HRQOL), along with improved asthma symptoms and lung function compared with placebo, according to the MUSCA* study.
Pearl Toh, 6 days ago
Treatment with abiraterone acetate and prednisone for metastatic prostate cancer (mPC) in patients who responded poorly to initial androgen-deprivation therapy (ADT) showed encouraging results with favourable overall survival (OS) to historical controls, although the prespecified criteria for a positive result was not met , according to the S1014* trial.
5 days ago
Blood pressure (BP) ≥140/90 mm Hg appears to increase the risk of maternal complications and adverse foetal outcomes, irrespective of the number of medications used, a study suggests. However, the greatest risk is observed among pregnant women taking multiple agents and whose BP levels are within the aforementioned range.
7 days ago
Relapse after randomization is more likely to occur in patients with severe baseline hallucinations, reports a new study. In addition, the presence of baseline hallucinations is associated with a greater risk of relapse after discontinuation of risperidone vs continued risperidone treatment.

Prescriptive hip exercises improve pain, satisfaction in patients with LBP

9 days ago

Including manual therapy of the hip joints and prescriptive exercise programmes of the gluteal muscles in a low-back pain (LBP) intervention may improve clinical outcomes in individuals with a primary complaint of LBP, a new randomized controlled trial (RCT) shows.

Investigators randomly assigned 90 participants to receive either LBP treatment only (LBP) or both LBP and prescriptive hip treatment (LBP +HIP). Only patients at least 18 years of age who presented a primary complaint of LBP and showed improvements in pain and/or range of motion during the assessment visit were included.

Aside from a pragmatic, guideline-oriented treatment for LBP, participants in the LBP + HIP group received prescriptive hip treatments, which included exercises that targeted both hips and the hip joint. The primary outcome of the study was Modified Oswestry Disability Index (ODI) scores.

Only 84 of the 90 participants (aged 46.1 [16.2] years)completed all follow-up measures and were thus included in the analysis. Of the six lost to follow-up, two belonged to the LBP + HIP group and four to the LBP group.

The average duration of back pain symptoms was 19.7±7.2 and 20.3±6.5 weeks in the LBP and LBP + HIP groups, respectively. Baseline ODI scores were 36.7±2.1 and 36.4±1.5, and baseline numeric pain rating scale (NPRS) scores were 5.4±0.3 and 5.1±0.3, respectively. There were no significant differences in any of the baseline characteristics between the two groups.

At the end of two weeks, there were no significant between-group differences in ODI (mean difference [MD], 2.6; 95 percent CI, 0.67 to 4.43; p=0.01) and NPRS (MD, 0.2; -0.6 to 0.5; p=0.27). The LBP + HIP group had significant improvements in patient satisfaction (p<0.01) and global rating of change (GRoC; p<0.01).

At discharge, the LBP + HIP group had significantly more favourable ODI (p=0.03), NPRS (p=0.02), patient satisfaction (p<0.01) and GRoC (p<0.01).

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Pearl Toh, 7 days ago
Mepolizumab added on to standard of care for patients with severe eosinophilic asthma better improves health-related quality of life (HRQOL), along with improved asthma symptoms and lung function compared with placebo, according to the MUSCA* study.
Pearl Toh, 6 days ago
Treatment with abiraterone acetate and prednisone for metastatic prostate cancer (mPC) in patients who responded poorly to initial androgen-deprivation therapy (ADT) showed encouraging results with favourable overall survival (OS) to historical controls, although the prespecified criteria for a positive result was not met , according to the S1014* trial.
5 days ago
Blood pressure (BP) ≥140/90 mm Hg appears to increase the risk of maternal complications and adverse foetal outcomes, irrespective of the number of medications used, a study suggests. However, the greatest risk is observed among pregnant women taking multiple agents and whose BP levels are within the aforementioned range.
7 days ago
Relapse after randomization is more likely to occur in patients with severe baseline hallucinations, reports a new study. In addition, the presence of baseline hallucinations is associated with a greater risk of relapse after discontinuation of risperidone vs continued risperidone treatment.